MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03558nam a22004097a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
CUTN |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20201222115516.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
201222b ||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781118696217 (pdf) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781118696200 (epub) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781118622124 (cloth) |
| 041 ## - LANGUAGE CODE |
|---|
| Language |
English |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.994061 |
| Edition number |
23 |
| Item number |
TOD |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Todd, Adam A., |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Anticancer therapeutics : |
| Remainder of title |
From Drug Discovery to Clinical Applications / |
| Statement of responsibility, etc |
Adam Todd, Paul W. Groundwater, Jason Gill. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
First edition. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Hoboken, NJ : |
| Name of publisher, distributor, etc |
Wiley, |
| Date of publication, distribution, etc |
2018. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xii, 434p.: |
| Other physical details |
ill.; |
| Dimensions |
25cm |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Title |
Section 1 Introduction -- |
| -- |
Section 2 The Anticancer Agents -- |
| -- |
Section 3 The Cancers. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
An integrated presentation of the basic science and clinical applications of anticancer agents Aimed at both undergraduate and postgraduate readers, this unique text provides readers with a fully-integrated presentation of all aspects of the science of anticancer drugs, including their chemistry, pharmacology, and clinical applications. After heart disease, cancer is the number one killer worldwide, and the tumor microenvironment is forever changing, creating an ever-greater demand for safer, more effective anticancer agents. In response to that demand, the $100 billion cancer drug market continues to grow, with our increased understanding of cancer leading to new drugs being used clinically almost every year. Anticancer Therapeutics is divided into three sections. Section 1 is an introduction to cancer and therapeutics, and covers the etiology and cellular and molecular basis of cancer. In Section 2, the authors focus on the anticancer agents-their discovery, synthesis, mode of action, mechanisms of resistance, and adverse reactions. Section 3 focuses on specific cancers, explaining how and why the various agents discussed in Section 2 are used, both individually and in combination, to treat different cancers.-Integrates aspects of basic science, including chemistry and pharmacology and clinical medicine in relation to cancer therapeutics -Written by an author team comprising specialists in medicinal chemistry, pharmacology, and oncology -Features full-color images throughout illustrating how drugs bind to cellular targets and exert their pharmacological effect -Divided into three sections, covering the etiology and cellular and molecular basis of cancer, anticancer agents, and drug applications for different cancers. Providing the reader with an integrated understanding of all aspects of the science of anticancer agents, this is an ideal textbook for undergraduates studying medicine, nursing, medicinal chemistry, pharmacy, pharmacology and other allied heath / life sciences. It is also a valuable bench reference for pharmacists, medics, and pharmaceutical researchers working in both academia and industry. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Neoplasms |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Neoplasms |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Antineoplastic Agents |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Discovery |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Groundwater, Paul W., |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Gill, Jason H., |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
General Books |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Dates associated with a name |
1982- |
| Relator term |
author. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| General subdivision |
drug therapy |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| General subdivision |
physiopathology |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Relator term |
author. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Dates associated with a name |
1973- |
| Relator term |
author. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Display text |
Print version: |
| Main entry heading |
Todd, Adam A., 1982- author. |
| Title |
Anticancer therapeutics |
| Edition |
First edition. |
| Place, publisher, and date of publication |
Hoboken, NJ : Wiley, 2017 |
| International Standard Book Number |
9781118622124 |
| Record control number |
(DLC) 2017024305 |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
|---|
| a |
7 |
| b |
cbc |
| c |
origcop |
| d |
1 |
| e |
ecip |
| f |
20 |
| g |
y-gencatlg |
